Catalyst Pharmaceuticals Inc
CPRX21.395USD
+0.275+1.30%
交易中 （美東）報價延遲15分鐘
2.61B總市值
13.22本益比TTM
關於 Catalyst Pharmaceuticals Inc 公司
Catalyst Pharmaceuticals, Inc. 是一家商業階段的生物製藥公司。該公司專注於開發和商業化用於治療罕見和難治疾病的一流藥物。其旗艦商業產品是 FIRDAPSE（氨苯吡啶）片劑 10 毫克 (mg)，獲准用於治療成人和 6 至 17 歲兒童的 Lambert-Eaton 肌無力綜合徵 (LEMS)。該公司還將 FYCOMPA（吡侖帕奈）CIII 作爲處方藥進行營銷，可單獨使用或與其他藥物一起使用，用於治療 4 歲及以上癲癇患者的局竈性發作（伴或不伴繼發性全身性癲癇），以及與其他藥物一起使用，用於治療 12 歲及以上癲癇患者的原發性全身性強直陣攣性癲癇。其產品組合還包括 AGAMREE（vamorolone），一種用於治療杜氏肌營養不良症 (DMD) 的 40 mg/ml 口服混懸液。 vamorolone 是一種用於治療 DMD 患者的皮質類固醇藥物。
公司簡介
公司代碼CPRX
公司名稱Catalyst Pharmaceuticals Inc
上市日期Nov 08, 2006
CEOMr. Richard J. (Rich) Daly
員工數量181
證券類型Ordinary Share
年結日Nov 08
公司地址355 Alhambra Circle
城市CORAL GABLES
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編33134
電話13055292522
網址https://catalystpharma.com/
公司代碼CPRX
上市日期Nov 08, 2006
CEOMr. Richard J. (Rich) Daly
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Patrick James Mcenany
Mr. Patrick James Mcenany
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
4.28M
-4.46%
Dr. Steven R. Miller, Ph.D.
Dr. Steven R. Miller, Ph.D.
Executive Vice President, Chief Operating Officer, and Chief Scientific Officer
Executive Vice President, Chief Operating Officer, and Chief Scientific Officer
949.66K
--
Mr. Donald A. Denkhaus
Mr. Donald A. Denkhaus
Independent Director
Independent Director
495.08K
--
Dr. David S. Tierney, M.D.
Dr. David S. Tierney, M.D.
Independent Director
Independent Director
355.62K
--
Mr. Richard J. (Rich) Daly
Mr. Richard J. (Rich) Daly
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
199.76K
-25.95%
Mr. Brian D. Elsbernd, J.D.
Mr. Brian D. Elsbernd, J.D.
Chief Compliance Officer, Chief Legal Officer
Chief Compliance Officer, Chief Legal Officer
188.56K
--
Dr. Gary Ingenito, M.D., Ph.D.
Dr. Gary Ingenito, M.D., Ph.D.
Chief Medical Officer and Regulatory Officer
Chief Medical Officer and Regulatory Officer
68.87K
--
Dr. Preethi Sundaram, Ph.D.
Dr. Preethi Sundaram, Ph.D.
Chief Strategy Officer
Chief Strategy Officer
41.08K
-8.72%
Ms. Molly Harper
Ms. Molly Harper
Lead Independent Director
Lead Independent Director
6.75K
--
Ms. Tamar Thompson
Ms. Tamar Thompson
Independent Director
Independent Director
1.41K
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Patrick James Mcenany
Mr. Patrick James Mcenany
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
4.28M
-4.46%
Dr. Steven R. Miller, Ph.D.
Dr. Steven R. Miller, Ph.D.
Executive Vice President, Chief Operating Officer, and Chief Scientific Officer
Executive Vice President, Chief Operating Officer, and Chief Scientific Officer
949.66K
--
Mr. Donald A. Denkhaus
Mr. Donald A. Denkhaus
Independent Director
Independent Director
495.08K
--
Dr. David S. Tierney, M.D.
Dr. David S. Tierney, M.D.
Independent Director
Independent Director
355.62K
--
Mr. Richard J. (Rich) Daly
Mr. Richard J. (Rich) Daly
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
199.76K
-25.95%
Mr. Brian D. Elsbernd, J.D.
Mr. Brian D. Elsbernd, J.D.
Chief Compliance Officer, Chief Legal Officer
Chief Compliance Officer, Chief Legal Officer
188.56K
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月16日 週五
更新時間: 5月16日 週五
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
13.46%
The Vanguard Group, Inc.
6.95%
State Street Global Advisors (US)
4.53%
McEnany (Patrick James)
3.51%
Deerfield Management Company, L.P.
2.81%
Other
68.75%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
13.46%
The Vanguard Group, Inc.
6.95%
State Street Global Advisors (US)
4.53%
McEnany (Patrick James)
3.51%
Deerfield Management Company, L.P.
2.81%
Other
68.75%
股東類型
持股股東
佔比
Investment Advisor
43.94%
Investment Advisor/Hedge Fund
24.40%
Hedge Fund
8.56%
Individual Investor
6.05%
Research Firm
4.41%
Pension Fund
1.27%
Bank and Trust
0.44%
Family Office
0.17%
Sovereign Wealth Fund
0.10%
Other
10.67%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
675
109.00M
89.36%
-4.26M
2025Q1
693
109.47M
89.76%
-3.79M
2024Q4
658
108.09M
89.06%
-2.57M
2024Q3
628
104.82M
88.36%
-8.18M
2024Q2
597
106.41M
90.13%
-15.99M
2024Q1
590
105.68M
89.66%
-4.79M
2023Q4
569
93.52M
87.71%
-15.08M
2023Q3
548
90.12M
84.55%
-19.61M
2023Q2
542
91.66M
86.51%
-22.59M
2023Q1
518
97.83M
92.70%
-11.38M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
16.42M
13.46%
-409.06K
-2.43%
Mar 31, 2025
The Vanguard Group, Inc.
8.47M
6.95%
+64.49K
+0.77%
Mar 31, 2025
State Street Global Advisors (US)
5.53M
4.53%
-266.12K
-4.59%
Mar 31, 2025
McEnany (Patrick James)
4.28M
3.51%
-200.00K
-4.46%
Jun 09, 2025
Deerfield Management Company, L.P.
3.42M
2.81%
+289.14K
+9.23%
Mar 31, 2025
Renaissance Technologies LLC
2.96M
2.42%
+250.20K
+9.25%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.77M
2.27%
+100.08K
+3.75%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.19M
1.79%
-825.61K
-27.40%
Mar 31, 2025
Fundsmith LLP
2.15M
1.76%
+2.15M
--
Mar 31, 2025
Goldman Sachs & Company, Inc.
1.77M
1.45%
+371.01K
+26.53%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Neuroscience and Healthcare ETF
3.69%
Tema Neuroscience and Mental Health ETF
2.92%
Invesco Biotechnology & Genome ETF
2.32%
Invesco S&P SmallCap 600 GARP ETF
2.01%
Invesco S&P SmallCap Health Care ETF
1.78%
AAM Sawgrass US Small Cap Quality Growth ETF
1.65%
Invesco Dorsey Wright Healthcare Momentum ETF
1.64%
Pacer US Small Cap Cash Cows Growth Leaders ETF
1.56%
Janus Henderson Small Cap Growth Alpha ETF
1.52%
Janus Henderson Small/Mid Cap Growth Alpha ETF
1.44%
查看更多
iShares Neuroscience and Healthcare ETF
佔比3.69%
Tema Neuroscience and Mental Health ETF
佔比2.92%
Invesco Biotechnology & Genome ETF
佔比2.32%
Invesco S&P SmallCap 600 GARP ETF
佔比2.01%
Invesco S&P SmallCap Health Care ETF
佔比1.78%
AAM Sawgrass US Small Cap Quality Growth ETF
佔比1.65%
Invesco Dorsey Wright Healthcare Momentum ETF
佔比1.64%
Pacer US Small Cap Cash Cows Growth Leaders ETF
佔比1.56%
Janus Henderson Small Cap Growth Alpha ETF
佔比1.52%
Janus Henderson Small/Mid Cap Growth Alpha ETF
佔比1.44%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
